- Asian shares trade mixed as technology shares in China drop amid delisting fears.
- North Korea’s missile test also challenge the market optimism taking clues from AstraZeneca update, stimulus hopes.
- US GDP, central bankers’ comments will be the key.
Asian equities fail to track S&P 500 Futures to the north as headlines concerning Beijing’s technology stocks and North Korea weigh on the sentiment ahead of Thursday’s European session. In doing so, market-friendly news from AstraZeneca and hopes of further US stimulus fails to please investors from the region.
While portraying the mood, MSCI’s index of Asia–Pacific shares outside Japan drops 0.15% whereas Japan’s Nikkei 225 gains 0.75% by the press time. Further, Australia’s ASX 200 and New Zealand’s NZX 50 alternate gains with losses amid mixed clues from China and a lack of major catalysts at home.
Markets in China, Hong Kong, Indonesia and India are mildly offered as the US eyes tightening conditions for the foreign firms to stay on the American bourses. The same could oust some of the technology giants from Beijing and may escalate the Sino-American tussle.
It’s worth mentioning that the dragon nation has recently been suffering from equity sell-off and the same could be the reason behind the latest rumors suggesting China’s state funds directly buying from the market to help domestic companies.
Elsewhere, South Korea’s KOSPI ignores news claiming two missiles fired by its neighbor, i.e. North Korea. Though, the Asia-Pacific caution limits the index gains.
S&P 500 Futures snap a two-day losing streak as AstraZeneca unveils 76% efficacy over the covid variants and shrug off allegations concerning side-effects. Also positive for the market sentiment is the extension of the Paycheck Protection Program (PPP) beyond the March 31 expiry as well as hints over a $3.0 trillion infrastructure spending plan.
It should, however, be noted that the US 10-year Treasury yields bounce off a one-week low to rise for the first time in four days, around 1.63% by the time of writing.
Moving on, key central bankers from the UK, the US and Europe are up for speeches and can move the markets. Also important is the US Q4 GDP figures.
Read: The February Grab-Bag Preview: Personal Income, Spending, Core PCE Prices and GDP
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
EUR/USD drops below 1.0800 after German Retail Sales data
EUR/USD has come under fresh selling pressure and trades below 1.0800 after the data from Germany showed that Retail Sales declined by 1.9% MoM in February. Resurgent US Dollar demand is adding to the downside in the pair. US data are next in focus.
GBP/USD stays weak near 1.2600 amid market caution
GBP/USD remains defensive near 1.2600 in European trading on Thursday. The hawkish tone from Fed Governor Christopher Waller keeps the US Dollar afloat amid a cautious trading environment ahead of key US data releases and the Good Friday trading lull.
Gold price holds strength ahead of US core PCE inflation
Gold price holds onto gains near $2,200 in Thursday’s European session. The precious metal exhibits firm footing ahead of the United States core PCE Price Index data for February, which will be published on Friday.
XRP price falls to $0.60 support as Ripple ruling doesn’t help Coinbase lawsuit against SEC
XRP programmatic sales ruling by Judge Torres was completely rejected by another US Court that ruled in favor of the SEC in a lawsuit against Coinbase.
Portfolio rebalancing and reflation trades emerge into Q2
Yesterday’s price action pointed at a possible end-of-quarter portfolio rebalancing as the session saw the laggards of the quarter like Apple and Tesla gain, and the stars like Microsoft and Nvidia retreat.